Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug evolution concept in drug design: 2. Chimera method.

A Kluczyk1, T Kiyota, C Lazar

  • 1National Research Council Canada, Biotechnology Research Institute, 6100 Royalmount Ave., Montréal, QC, H4P 2R2, Canada.

Medicinal Chemistry (Shariqah (United Arab Emirates))
|June 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction to the special issue on Environmental Neurology.

Journal of the neurological sciences·2026
Same author

(5,3) SWCNT-doping phosphorus-magnesium: Difference in adsorption of cardiovascular drugs.

Journal of molecular graphics & modelling·2025
Same author

Study of clopidogrel and clonidine interactions for cardiovascular formulations: progress from DFT modeling.

Nanoscale advances·2025
Same author

AMINO ACIDS METABOLOMIC SIGNATURE OF BLOOD PRESSURE VARIABILITY In Type 2 Diabetes.

Acta endocrinologica (Bucharest, Romania : 2005)·2023
Same author

METABOLOMIC ANALYSIS OF NORMAL WEIGHT, HEALTHY AND UNHEALTHY OBESITY: AMINO ACID CHANGE ACROSS THE SPECTRUM OF METABOLIC WELLBEING IN WOMEN.

Acta endocrinologica (Bucharest, Romania : 2005)·2022
Same author

Relevance of silica surface morphology in Ampyra adsorption. Insights from quantum chemical calculations.

RSC advances·2022

Drug evolution and chimera methods accelerate rational drug design by creating diverse chemical libraries. This approach identifies drug candidates more efficiently and cost-effectively than traditional strategies.

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Computational Chemistry

Background:

  • Traditional drug design is costly and time-consuming.
  • Biological evolution principles can inform chemical library development.
  • Novel methods are needed to improve drug candidate identification efficiency.

Purpose of the Study:

  • To introduce and validate the drug evolution and chimera methods for rational drug design.
  • To demonstrate the creation of general chemical libraries for drug candidate discovery.
  • To enable identification of potential drugs with improved success rates and reduced costs.

Main Methods:

  • Implementing the drug evolution concept for chemical library creation.
  • Utilizing the chimera method: grafting building blocks onto scaffolds.

Related Experiment Videos

  • Developing libraries based on para-aminobenzoic acid and salicylic acid scaffolds.

    • Main Results:

    • Successfully created drug-enriched chimera libraries.
    • Identified a high number of recognized drugs with diverse therapeutic activities.
    • Demonstrated interaction with a broad spectrum of molecular targets.

    Conclusions:

    • The chimera method offers an efficient approach to novel drug candidate discovery.
    • Libraries generated do not require prior knowledge of disease or molecular targets.
    • High-throughput screening can reveal further therapeutic effects of identified candidates.